Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewCardiologyGenetics Open Access | 10.1172/jci.insight.204278

Progressive cardiac phenotypes and reduced reversibility from long-term CUGexp RNA expression in a DM1 mouse model

Rong-Chi Hu,1 Mohammadreza Tabary,2 Xander H.T. Wehrens,2 and Thomas A. Cooper1

1Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States of America

2Department of Medicine (Cardiology section), Baylor College of Medicine, Houston, United States of America

Find articles by Hu, R. in: PubMed | Google Scholar

1Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States of America

2Department of Medicine (Cardiology section), Baylor College of Medicine, Houston, United States of America

Find articles by Tabary, M. in: PubMed | Google Scholar

1Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States of America

2Department of Medicine (Cardiology section), Baylor College of Medicine, Houston, United States of America

Find articles by Wehrens, X. in: PubMed | Google Scholar |

1Department of Pathology & Immunology, Baylor College of Medicine, Houston, United States of America

2Department of Medicine (Cardiology section), Baylor College of Medicine, Houston, United States of America

Find articles by Cooper, T. in: PubMed | Google Scholar |

Published March 19, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.204278.
Copyright © 2026, Hu et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published March 19, 2026 - Version history
View PDF
Abstract

Myotonic Dystrophy Type 1 (DM1) is caused by an expanded CTG repeat in the DMPK gene, resulting in mutant transcripts that form expanded CUG (CUGexp) RNA foci and sequester muscleblind-like (MBNL) RNA-binding proteins. DM1 is multisystemic with progressive worsening of disease manifestations in affected tissues. Disease progression is attributed to somatic expansion of the CTG repeats with age, resulting in production of CUGexp RNA with enhanced intrinsic toxicity due to increased MBNL sequestration. To determine the degree to which cardiac disease progression can occur independently of repeat expansion, we used a transgenic DM1 mouse model with inducible heart-specific expression of a stable, interrupted 960-CUG repeat RNA. Sustained CUGexp RNA expression caused progressive cardiac enlargement, contractile dysfunction, conduction delay, myocardial fibrosis, and reduced survival, while MBNL-dependent splicing defects remained static, consistent with the stable repeat length. We also determined the degree of reversibility after different periods of CUGexp RNA expression by shutting off the repeat-containing transgene. Suppression of CUGexp RNA expression rescued cardiac abnormalities, but reversibility declined with longer exposure to the toxic RNA. These findings demonstrate that prolonged expression of stable CUGexp RNA drives progressive cardiac pathology, revealing a mechanism of disease progression in DM1 in addition to somatic expansion.

Supplemental material

View Unedited blot and gel images

View Dataset S1_ECG evaluation for aging timeline

View Dataset S2_ECG evaluation for aging rescue

View

Version history
  • Version 1 (March 19, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts